Home / Expertise / Life Sciences & Healthcare
side view of scientist looking into microscope in bright research lab

Life Sciences & Healthcare

Russia

With over 150 international specialist lawyers across CMS and the support of the Lifesciences Asia-Pacific Network (LAN), we understand the scientific and commercial as well as the legal imperatives affecting your life sciences & healthcare business. We work with and have established long-term relationships with the top 100 life sciences & healthcare companies in the areas of pharmaceuticals, medical devices, biotechnology, agriculture and food, including the top 20 global pharmaceutical companies and nine out of the top ten global medical device companies.

Our experts, many of whom have worked in-house in your sector, have developed a shared capability in the areas of pharmaceuticals, biotechnology, medical devices and diagnostics. With active memberships in major industry associations such as the ABPI, ABHI, BIVDA, PAGB, EUCOMED and EFPIA, we help shape the legal frameworks impacting the life sciences & healthcare sector. We regularly advise our clients on their day-to-day operational needs such as support with advertisement and promotion of medicine, public sector procurement, pricing and reimbursement, patent enforcement, commercial and clinical trial agreements as well as regulatory advice. Equally, when you need life sciences & healthcare specialist advice for strategic agreements, planning a corporate transaction or embarking on litigation (whether product liability or otherwise), we have a team that is well versed in the industry issues to help you.

Read more Read less

Feed

Show only
28 Oct 19
Do­ing busi­ness in Rus­sia 2019
31 Jan 20
UK In­tel­lec­tu­al Prop­erty Of­fice finds that pat­ent law does not cater...
The UK In­tel­lec­tu­al Prop­erty Of­fice has found that DABUS is not a per­son and so can­not be con­sidered an in­vent­or of a pat­ent. DABUS is an ar­ti­fi­cial in­tel­li­gence (AI) ma­chine. The UKIPO ac­cep­ted the in­dic­a­tion...
September 2019
Health­care M&A
Get­ting The Deal Through
17 Jan 20
New guid­ance on cy­ber­se­cur­ity for med­ic­al devices pub­lished
In Decem­ber 2019, the Med­ic­al Device Co­ordin­a­tion Group (“MD­CG”) is­sued a new guid­ance to help med­ic­al device man­u­fac­tur­ers meet the cy­ber­se­cur­ity re­quire­ments in the Med­ic­al Devices Reg­u­la­tion (“MDR”)...
24/06/2019
Prices for es­sen­tial drug list medi­cines sub­ject to...
Ja­pan­ese ver­sion
15 Jan 20
In­tro­duc­tion of man­dat­ory drug la­belling post­poned to 1 Ju­ly 2020
On 28 Decem­ber 2019, a law* came in­to force that post­pones the dead­line for the in­tro­duc­tion of a track and trace sys­tem for medi­cines un­til 1 Ju­ly 2020. Ini­tially, la­belling with Data Mat­rix codes was...
24/05/2019
CMS Rus­sia earns 33 re­cog­ni­tions by Best Law­yers 2020
15 Jan 20
Can newly dis­covered can­nabis com­pounds be pro­tec­ted by pat­ents?
A break­through dis­cov­ery has re­cently hit the news: tet­rahy­drocan­nabi­phorol (THCP) and can­na­bid­i­phorol (CB­DP), two new can­nabin­oid com­pounds, have been dis­covered in Can­nabis sativa and char­ac­ter­ised...
11/03/2019
Cham­bers Europe 2019: CMS con­firms its lead­ing po­s­i­tion...
27 Dec 19
Elec­tron­ic la­bour books to be avail­able in Rus­sia from 2021
Em­ploy­ment his­tory re­cords will have to be held in elec­tron­ic form from 1 Janu­ary 2021. Le­gis­lat­ive amend­ments which provide for this and oth­er re­lated re­quire­ments will come in­to force on 1 Janu­ary 2020....
06/12/2018
CMS con­firms its lead­ing po­s­i­tion on the Rus­si­an leg­al...
09 Dec 19
Fines for breach of per­son­al data loc­al­isa­tion rules fi­nally ad­op­ted
The Pres­id­ent has signed a law* in­tro­du­cing fines for the breach of per­son­al data loc­al­isa­tion rules. The law is ef­fect­ive from 2 Decem­ber 2019. The law provides for fines ran­ging from RUB 1m (EUR...